Lower HDAC6 mRNA expression and promoter hypomethylation are associated with RA susceptibility
Tzu-Jung Fang1, Chia-Hui Lin2, Yuan-Zhao Lin2
1Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Taiwan; Division of Geriatrics and Gerontology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Taiwan.
Background/Purpose:
Recent studies showed that Histone deacetylases 6 (HDAC6) inhibitors could improve arthritis in rheumatoid arthritis (RA) rodent models, whereas lower HDAC6 expression was observed in RA patients' synovial fibroblasts, raising the concerns to use HDAC6 inhibitors to treat RA patients. In the present study, we investigated the involvement of HDAC6 mRNA expression and promoter methylation in RA.
Methods:
The DNA and RNAs were extracted from the peripheral blood mononuclear cells (PBMCs) from 138 RA patients and 102 healthy controls. The pyrosequencing technique was used for promoter methylation analysis. The quantitative real-time polymerase chain reaction was used to determine the HDAC6 mRNA expression. The patients' clinical characteristics and disease biomarkers were recorded when blood sampling.
Results:
The HDAC6 mRNA expression was lower in the RA patients than controls (p = 0.001). The RA patients had significant hypomethylation of the HDAC6 promoter (p < 0.001). The HDAC6 promoter was hypo-methylated in the -229, -225, -144, and -142 CpG sites in RA patients (p < 0.05). Unexpectedly, promoter methylation and mRNA expression of the HDAC6 gene were positively associated (p < 0.001). The HDAC6 mRNA expression and promoter methylation status were associated with the risk of RA (p = 0.006 and 0.002, respectively). The inflammatory cytokines, TNF-α and IL-6, were significantly increased after HDAC6 knockdown in PMA-stimulated THP1 cells and SW982 cells (p < 0.05).
Conclusion:
The HDAC6 mRNA expression and promoter methylation were lower in RA patients. Both HDAC6 mRNA expression level and promoter hypomethylation were associated the susceptibility of RA. HDAC6 inhibitors seem not proper for RA patients' treatment.
Insights
Lower Histone deacetylases 6 (HDAC6) mRNA expression and promoter hypomethylation are linked to rheumatoid arthritis (RA) susceptibility in patients. These findings suggest HDAC6 inhibitors may not be suitable for treating RA.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Histone deacetylases 6 (HDAC6) inhibitors show promise in rheumatoid arthritis (RA) rodent models.
- However, reduced HDAC6 expression in RA patients' synovial fibroblasts raises concerns about inhibitor efficacy.
- This study investigates HDAC6 mRNA expression and promoter methylation in RA patients.
Purpose of the Study:
- To examine the role of HDAC6 mRNA expression in rheumatoid arthritis (RA).
- To analyze HDAC6 promoter methylation patterns in RA patients.
- To determine the association between HDAC6 expression, methylation, and RA risk.
Main Methods:
- Extracted DNA and RNA from peripheral blood mononuclear cells (PBMCs) of 138 RA patients and 102 healthy controls.
- Utilized pyrosequencing for HDAC6 promoter methylation analysis.
- Employed quantitative real-time polymerase chain reaction (qRT-PCR) for HDAC6 mRNA expression quantification.
Main Results:
- RA patients exhibited significantly lower HDAC6 mRNA expression and HDAC6 promoter hypomethylation compared to controls.
- Specific CpG sites (-229, -225, -144, -142) in the HDAC6 promoter were hypomethylated in RA patients.
- HDAC6 mRNA expression and promoter methylation were positively correlated and associated with RA risk.
- HDAC6 knockdown in cell lines increased inflammatory cytokines TNF-α and IL-6.
Conclusions:
- Lower HDAC6 mRNA expression and promoter hypomethylation characterize rheumatoid arthritis (RA) patients.
- Both reduced HDAC6 expression and promoter hypomethylation are associated with RA susceptibility.
- HDAC6 inhibitors may not be an appropriate therapeutic strategy for RA patients.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Epigenetic Regulation
X-chromosome...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway


